70 pending office actions • 27 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19090228 | PATHOGEN DETECTION USING NEXT GENERATION SEQUENCING | The Regents of the University of California | DHARITHREESAN, NIDHI | 1686 | Final Rejection | Mar 25, 2025 |
| 18786394 | RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES | The Regents of the University of California | ANGELL, JON E | 1637 | Non-Final OA | Jul 26, 2024 |
| 18664227 | LIDAR SYSTEM GENERATING MULTIPLE LIDAR OUTPUT SIGNALS | Silc Technologies, Inc. | QI, ZHENGQING J | 3645 | Non-Final OA | May 14, 2024 |
| 18636709 | SILICON MOLD FOR HIGH TEMPERATURE COMPRESSION MOLDING AND PREPARATION METHOD THEREOF | Huatong Optical Technology (Zhejiang) Co., Ltd. | DEHGHAN, QUEENIE S | 1741 | Non-Final OA | Apr 16, 2024 |
| 18681457 | GENETICALLY ENGINEERED CELL-DERIVED VACCINES | The Regents of the University of California | CHHAY, BONIRATH | 1645 | Non-Final OA | Feb 05, 2024 |
| 18290679 | PTPRS IN AUTOIMMUNITY | The Regents of the University of California | KRUSE, DAVID H | 1663 | Non-Final OA | Jan 19, 2024 |
| 18573359 | NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE 2A, 2B or 2C AGONISTS | Ldn Pharma Limited | SAMSELL, RILLA MARIE | 1624 | Non-Final OA | Dec 21, 2023 |
| 18573362 | TREATMENT FOR AUTOIMMUNE DISEASES | Ldn Pharma Limited | MCMILLIAN, KARA RENITA | 1623 | Non-Final OA | Dec 21, 2023 |
| 18572651 | COMPOSITIONS COMPRISING AN AGONIST OF 5-HYDROXYTRYPTAMINE (5-HT) RECEPTOR SUBTYPE 3 | Ldn Pharma Limited | ULLMAN, AARON RAFANAN | 1628 | Non-Final OA | Dec 20, 2023 |
| 18563704 | MOISTURE AND OIL BARRIER | Kemira Oyj | AHMED, SHEEBA | 1787 | Non-Final OA | Nov 22, 2023 |
| 18285000 | MODIFIED VIRUSES AND VIRAL PARTICLES, METHODS OF MAKING, AND USES THEREOF | The Regents of the University of California | BABIC, CHRISTOPHER M | 1633 | Non-Final OA | Sep 29, 2023 |
| 18285227 | COMPOSITIONS AND METHODS FOR MODULTING INFLAMMATORY AND DEGENERATIVE DISORDER | UNIVERSITY OF SOUTHERN CALIFORNIA | LEE, JIA-HAI | 1658 | Non-Final OA | Sep 29, 2023 |
| 18285222 | BLOCKING OLIGONUCLEOTIDES FOR THE SELECTIVE DEPLETION OF NON-DESIRABLE FRAGMENTS FROM AMPLIFIED LIBRARIES | Illumina, Inc. | CASH, KAILEY ELIZABETH | 1683 | Non-Final OA | Sep 29, 2023 |
| 18284783 | DETECTION ASSAY | Randox Teoranta | HAQ, SHAFIQUL | 1678 | Non-Final OA | Sep 28, 2023 |
| 18284682 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited | MCMILLIAN, KARA RENITA | 1623 | Non-Final OA | Sep 28, 2023 |
| 18280093 | USE OF MESENCHYMAL STEM CELLS OVEREXPRESSING PACER FOR THE TREATMENT OF DISEASES WITH INFLAMMATORY ORIGIN AND/OR COMPONENT | Universidad del Desarrollo | RAHMAN, MASUDUR | 1633 | Non-Final OA | Sep 01, 2023 |
| 18273710 | NALTREXONE COMPOSITIONS | Ldn Pharma Limited | ARNOLD, ERNST V | 1613 | Final Rejection | Jul 21, 2023 |
| 18273491 | THERAPIES FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH ABNORMAL EXPRESSION OF CDKL5 GENE | The Regents of the University of California | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | Non-Final OA | Jul 20, 2023 |
| 18271832 | RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF | The Regents of the University of California | ALLEN, SARAH ELIZABETH | 1637 | Non-Final OA | Jul 11, 2023 |
| 18271829 | INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS | Saga University | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Jul 11, 2023 |
| 18330163 | ASSAY TO IDENTIFY ANTI-CANCER AGENTS | Ldn Pharma Limited | HOWELL, THEODORE R | 1628 | Non-Final OA | Jun 06, 2023 |
| 18038145 | INTRAVENOUS IN FUSION SET AND ACCESSORY THEREFOR | Unknown | BOSWORTH, KAMI A | 3783 | Non-Final OA | May 22, 2023 |
| 18037968 | METHODS FOR USE IN PREVENTATIVE HEALTHCARE | Randox Laboratories Ltd. | LUSI, ELLIS FOLLETT | 1677 | Non-Final OA | May 19, 2023 |
| 18035070 | IMMUNE CHECKPOINT INHIBITOR | Randox Laboratories Ltd. | PUTTLITZ, KARL J | 1646 | Non-Final OA | May 02, 2023 |
| 18297593 | RECOMBINANTLY ENGINEERED POLYPEPTIDES CAPABLE OF RECYCLING NONCANONICAL COFACTORS | The Regents of the University of California | LEE, JIA-HAI | 1658 | Non-Final OA | Apr 07, 2023 |
| 18029606 | HIGH-THROUGHPUT METHOD FOR LP(A)-CHOLESTEROL QUANTITATION | The Regents of the University of California | LUSI, ELLIS FOLLETT | 1677 | Final Rejection | Mar 30, 2023 |
| 18028740 | COMPOSITION AND METHODS FOR MODULATING TCF4 GENE EXPESSION AND TREATING PITT HOPKINS SYNDROME | The Regents of the University of California | THUESON, HANNA MARIE | 1638 | Non-Final OA | Mar 27, 2023 |
| 18189147 | MOLECULAR RHEOSTAT FOR COFACTOR BALANCE | The Regents of the University of California | DRISCOLL, LORA E BARNHART | 3991 | Final Rejection | Mar 23, 2023 |
| 18026492 | ADSORBENT-BASED MEMBRANES AND USES THEREOF | The Regents of the University of California | PARENT, ALEXANDER RENE | 1795 | Non-Final OA | Mar 15, 2023 |
| 18026480 | CHARGED MEMBRANES INCORPORATED WITH POROUS POLYMER FRAMEWORKS | The Regents of the University of California | CHIU, TAK LIANG | 1777 | Non-Final OA | Mar 15, 2023 |
| 18026287 | HYBRID PROTOCOLS AND BARCODING SCHEMES FOR MULTIPLE SEQUENCING TECHNOLOGIES | The Regents of the University of California | DAUNER, JOSEPH G | 1682 | Non-Final OA | Mar 14, 2023 |
| 18119274 | DATA RESOLUTION IN LIDAR SYSTEMS | Silc Technologies, Inc. | HELLNER, MARK | 3645 | Non-Final OA | Mar 08, 2023 |
| 18025169 | RNA AND DNA BASE EDITING VIA ENGINEERED ADAR | The Regents of the University of California | HUTSON, RICHARD G | 1652 | Non-Final OA | Mar 07, 2023 |
| 18025104 | A Newborn Metabolic Vulnerability Model For Identifying Preterm Infants At Risk Of Adverse Outcomes, And Uses Thereof | UNIVERSITY OF IOWA RESEARCH FOUNDATION | DUNN, MCKENZIE A | 1678 | Non-Final OA | Mar 07, 2023 |
| 18022630 | siRNA AND USE THEREOF | Ohara Pharmaceutical Co., Ltd. | SHIN, DANA H | 1635 | Final Rejection | Feb 22, 2023 |
| 18111103 | IMMUNOMODULATORY OLIGOSACCHARIDES | The Regents of the University of California | BAKSHI, PANCHAM | 1623 | Final Rejection | Feb 17, 2023 |
| 18108005 | MAP4K3 SMALL MOLECULE DRUG INHIBITORS AND METHODS OF USE THEREOF | Arizona Board of Regents | ELENISTE, PIERRE PAUL | 1622 | Final Rejection | Feb 09, 2023 |
| 18107936 | IMMUNOMODULATORY OLIGOSACCHARIDES | The Regents of the University of California | BAKSHI, PANCHAM | 1623 | Final Rejection | Feb 09, 2023 |
| 18106995 | DATA REFINEMENT IN OPTICAL SYSTEMS | Silc Technologies, Inc. | HUTCHENS, CHRISTOPHER D. | 3647 | Non-Final OA | Feb 07, 2023 |
| 18104770 | SCANNING MULTIPLE LIDAR SYSTEM OUTPUT SIGNALS | Silc Technologies, Inc. | THATCHER, CLINT A | 3645 | Non-Final OA | Feb 01, 2023 |
| 18006011 | GUN SHOT RESIDUE FIELD KIT | VERITEQUE USA, INC. | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Jan 19, 2023 |
| 18016432 | RECOMBINANT MICROORGANISMS | The Regents of the University of California | DICKENS, AMELIA NICOLE | 1645 | Final Rejection | Jan 16, 2023 |
| 18097261 | OPTICAL BRIDGES FOR PHOTONIC INTEGRATED CIRCUITS | Silc Technologies, Inc. | TAVLYKAEV, ROBERT FUATOVICH | 2896 | Final Rejection | Jan 15, 2023 |
| 18013788 | A METHOD TO CALIBRATE NUCLEIC ACID LIBRARY SEEDING EFFICIENCY IN FLOWCELLS | Illumina, Inc. | WILDER, CYNTHIA B | 1681 | Final Rejection | Dec 29, 2022 |
| 18076001 | ANTI-AGING DERMATOLOGICAL COMPOSITIONS | Dr. Sabrina Ltd. | WRIGHT, SARAH C | 1619 | Non-Final OA | Dec 06, 2022 |
| 18072666 | CONTROL OF SIGNAL CHIRP IN LIDAR SYSTEMS | Silc Technologies, Inc. | CHILTON, CLARA GRACE | 3645 | Non-Final OA | Nov 30, 2022 |
| 17970508 | IDENTIFICATION OF CHIRP RATES | Silc Technologies, Inc. | NAPIER, JAMES WILBURN | 3645 | Non-Final OA | Oct 20, 2022 |
| 17920379 | UNIVERSAL PRIMERS FOR DETECTION OF BACTERIA, FUNGI AND EUKARYOTIC MICROORGANISMS | The Regents of the University of California | BERTAGNA, ANGELA MARIE | 1681 | Non-Final OA | Oct 20, 2022 |
| 18048386 | THERAPIES AND METHODS TO TREAT TLR2-MEDIATED DISEASES AND DISORDERS | The Regents of the University of California | SZPERKA, MICHAEL EDWARD | 1641 | Final Rejection | Oct 20, 2022 |
| 17918017 | COMPOSITION AND METHOD FOR INACTIVATING A VIRUS | Malcolm Robert Bates | ROMERO, KRISTEN WANG | 1624 | Non-Final OA | Oct 10, 2022 |
| 17914274 | ANTI-ACINETOBACTER BAUMANNII POLYCLONAL ANTIBODY (AB-pAb), AND USES THEREOF | The Regents of the University of California | ZEMAN, ROBERT A | 1645 | Final Rejection | Sep 23, 2022 |
| 17912313 | SCREENING METHODS TO IDENTIFY SMALL MOLECULE COMPOUNDS THAT PROMOTE OR INHIBIT THE GROWTH OF CIRCULATING TUMOR CELLS, AND USES THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA | SCHLIENTZ, LEAH H | 1618 | Non-Final OA | Sep 16, 2022 |
| 17945072 | COMBINING DATA FROM DIFFERENT SAMPLE REGIONS IN AN IMAGING SYSTEM FIELD OF VIEW | Silc Technologies, Inc. | HULKA, JAMES R | 3645 | Non-Final OA | Sep 14, 2022 |
| 17786913 | BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS | The Regents of the University of California | RAMIREZ, DELIA M | 1652 | Final Rejection | Jun 17, 2022 |
| 17781173 | NEW USE OF REGEND001 CELL AUTOLOGOUS DELIVERABLE PREPARATION IN TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | Regend Therapeutics Co., Ltd. | TICHY, JENNIFER M.H. | 1653 | Final Rejection | May 31, 2022 |
| 17775217 | BIOMARKER OF DRUG-INDUCED CELLULAR TOXICITY AND DEPRESSION | Randox Laboratories Ltd. | WESTERBERG, NISSA M | 1618 | Non-Final OA | May 06, 2022 |
| 17770625 | SPECIFIC THC DETECTION DEVICE | VERITEQUE USA, INC. | MARTIN, ALEA NATASHA | 1758 | Final Rejection | Apr 21, 2022 |
| 17767045 | COMPOSITIONS AND METHODS FOR REPROGRAMMING AGE-RESTRICTED NON-NEURONAL CELLS | The Regents of the University of California | TRAN, CHRISTINA L | 1637 | Final Rejection | Apr 06, 2022 |
| 17765383 | XBP1 ISOFORM MULTIPLEX ASSAY | Randox Teoranta | IVICH, FERNANDO NMN | 1678 | Final Rejection | Mar 30, 2022 |
| 17625442 | SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING CANCER CELLS | Kotai Biotechnologies, Inc. | MCCORMICK, CATHERINE LYNN | 1638 | Non-Final OA | Jan 07, 2022 |
| 17280003 | MESENCHYMAL STEM CELLS DERIVED FROM SYNOVIUM AND USES THEREOF | Inje University Industry-Academic Cooperation Foundation | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Non-Final OA | Dec 10, 2021 |
| 17437724 | CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID | Ldn Pharma Limited | MAHLUM, JONATHAN DAVIS | 1625 | Final Rejection | Sep 09, 2021 |
| 17435911 | METHOD FOR DETERMINING EFFICACY | Ldn Pharma Limited | MOSS, NATALIE M | 1653 | Final Rejection | Sep 02, 2021 |
| 17433573 | NATURAL KILLER CELL INDUCED CELLULAR VESICLES FOR CANCER THERAPY | The Regents of the University of California | MELCHIOR, JAMES RYLAND | 1644 | Final Rejection | Aug 24, 2021 |
| 17419239 | CAR T CELL METHODS AND CONSTRUCTS | Abintus Bio, Inc. | KIM, TAEYOON | 1631 | Non-Final OA | Jun 28, 2021 |
| 17294358 | DETECTION OF BLADDER CANCER | Randox Laboratories Ltd. | MONTGOMERY, ANN Y | 1678 | Final Rejection | May 14, 2021 |
| 17280746 | IDENTIFICATION AND ANALYSIS OF MICROBIAL SAMPLES BY RAPID INCUBATION AND NUCLEIC ACID ENRICHMENT | Illumina, Inc. | SWITZER, JULIET CAROLINE | 1682 | Final Rejection | Mar 26, 2021 |
| 17049320 | SPIKED PRIMERS FOR ENRICHMENT OF PATHOGEN NUCLEIC ACIDS AMONG BACKGROUND OF NUCLEIC ACIDS | The Regents of the University of California | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Oct 20, 2020 |
| 17025836 | GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA | The Regents of the University of California | DHAR, MATASHA | 1632 | Non-Final OA | Sep 18, 2020 |
| 16776405 | PATHOGEN DETECTION USING NEXT GENERATION SEQUENCING | The Regents of the University of California | DHARITHREESAN, NIDHI | 1686 | Final Rejection | Jan 29, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial